A. Bozdogan Et Al. , "Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results," Archives of Breast Cancer , vol.11, no.1, pp.67-74, 2024
Bozdogan, A. Et Al. 2024. Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results. Archives of Breast Cancer , vol.11, no.1 , 67-74.
Bozdogan, A., Emiroglu, S., Abuaisha, A., & DENİZ BAŞAR, Ö., (2024). Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results. Archives of Breast Cancer , vol.11, no.1, 67-74.
Bozdogan, Atilla Et Al. "Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results," Archives of Breast Cancer , vol.11, no.1, 67-74, 2024
Bozdogan, Atilla Et Al. "Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results." Archives of Breast Cancer , vol.11, no.1, pp.67-74, 2024
Bozdogan, A. Et Al. (2024) . "Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results." Archives of Breast Cancer , vol.11, no.1, pp.67-74.
@article{article, author={Atilla Bozdogan Et Al. }, title={Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results}, journal={Archives of Breast Cancer}, year=2024, pages={67-74} }